EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rubinstein–Taybi Syndrome: A Comprehensive Analysis of a Polish Cohort with Most Cases Due to Novel CREBBP and EP300 Variants

Agata Cieślikowska iD, Agnieszka Madej-Pilarczyk iD, Piotr Iwanowski, Katarzyna Iwanicka-Pronicka, Dorota Wicher iD, Maria Jędrzejowska, Dorota Jurkiewicz, Marzena Gawlik, Dorota Piekutowska-Abramczuk, Paulina Halat-Wolska iD, Jagoda Błaszkiewicz, Izabela Mendrek und 6 weitere

Genes · 2025

DOI: 10.3390/genes16101206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Agata Cieślikowska und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw, Poland. Hauptthemen laut MEDLINE: Rubinstein-Taybi Syndrome, E1A-Associated p300 Protein, CREB-Binding Protein. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was partially funding by the projects CMHI 235/15, S205/2024, MEiN 7071/IB/SN/2020, MEiN 7088/II-KDM/SN/2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rubinstein–Taybi syndrome (RSTS) is characterized by intellectual disability, short stature, distinctive facial dysmorphism, broad thumbs/halluces, hearing loss, congenital heart or renal defects, and cryptorchidism in males. Pathogenic variants in CREBBP (~90% of cases) or EP300 (~10%) underlie the disorder, with ~88% single nucleotide variants (SNVs) and ~12% copy number variants (CNVs) in CREBBP. Materials and Methods: We investigated 17 patients clinically diagnosed with RSTS at a tertiary hospital in Poland. Genetic confirmation was achieved by next-generation sequencing, multiplex ligation-dependent probe amplification (MLPA), array comparative genomic hybridization (aCGH), or Sanger sequencing.

Results

Pathogenic variants were identified in CREBBP (13/17, 76%) and EP300 (4/17, 24%). Variant types included frameshift indels (6/17, 35%), missense (4/17, 24%), nonsense (3/17, 18%), splice-site (2/17, 12%), and gross deletions (2/17, 12%). Notably, 13/17 (76%) were novel: ten in CREBBP (c.−49_12del, c.289C>T, c.1093_1096del, c.1094A>G, c.3178A>T, c.3401A>T, c.(3836+1_3837−1)_(4394+1_4395−1)del, c.4133+2T>G, c.4963dup, c.5028_5029dup) and three in EP300 (c.1942C>T, c.3044_3045del, c.4713_4722del). Among the novel CREBBP variants, eight occurred de novo and two had unknown inheritance. Two novel EP300 variants occurred de novo and one was of unknown origin.

Conclusions

This first Polish RSTS cohort demonstrates a considerable proportion of gross deletions (12% overall; 15% in CREBBP) and an unexpectedly high rate of novel variants (76%), suggesting possible population-specific differences. These findings underscore the genetic heterogeneity of RSTS and highlight the importance of comprehensive molecular diagnostics and studies in underrepresented populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rubinstein-Taybi SyndromeE1A-Associated p300 ProteinCREB-Binding ProteinHumansMaleFemalePolandChildChild, PreschoolAdolescentInfantPolymorphism, Single NucleotideDNA Copy Number VariationsCohort StudiesAdult

Stichwörter der Autor:innen

CREBBPEP300MLPARubinstein-Taybi syndromeaCGHmolecular diagnosisnext-generation sequencingnovel variantspopulation genetics

Substanzen

E1A-Associated p300 ProteinEP300 protein, humanCREB-Binding ProteinCREBBP protein, human

Autor:innen und Institutionen

  • Department of Medical Genetics, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw, Poland.
  • Department of Medical Genetics, Institute of Mother and Child, ul. Kasprzaka 17a, 01-211 Warsaw, Poland.
  • Department of Medical Genetics, Medical University of Warsaw, ul. Żwirki i Wigury 61, 02-091 Warsaw, Poland.

ORCID-Profile: Agata Cieślikowska, Agnieszka Madej-Pilarczyk, Dorota Wicher, Paulina Halat-Wolska, Krystyna Chrzanowska, Marlena Młynek, Małgorzata Krajewska-Walasek, Elżbieta Ciara

Förderung

  • This study was partially funding by the projects CMHI 235/15, S205/2024, MEiN 7071/IB/SN/2020, MEiN 7088/II-KDM/SN/2020

Zitieren

APA

Cieślikowska, A., Madej-Pilarczyk, A., Iwanowski, P., Iwanicka-Pronicka, K., Wicher, D., Jędrzejowska, M., Jurkiewicz, D., Gawlik, M., Piekutowska-Abramczuk, D., Halat-Wolska, P., Błaszkiewicz, J., Mendrek, I., Chrzanowska, K., Młynek, M., Stawiński, P., Kosińska, J., Krajewska-Walasek, M., & Ciara, E. (2025). Rubinstein–Taybi Syndrome: A Comprehensive Analysis of a Polish Cohort with Most Cases Due to Novel CREBBP and EP300 Variants. Genes. https://doi.org/10.3390/genes16101206

Vancouver

Cieślikowska A, Madej-Pilarczyk A, Iwanowski P, Iwanicka-Pronicka K, Wicher D, Jędrzejowska M, et al. Rubinstein–Taybi Syndrome: A Comprehensive Analysis of a Polish Cohort with Most Cases Due to Novel CREBBP and EP300 Variants. Genes. 2025. doi:10.3390/genes16101206

BibTeX
@article{Cielikowska2025,
  author = {Cieślikowska, Agata and Madej-Pilarczyk, Agnieszka and Iwanowski, Piotr and Iwanicka-Pronicka, Katarzyna and Wicher, Dorota and Jędrzejowska, Maria and Jurkiewicz, Dorota and Gawlik, Marzena and Piekutowska-Abramczuk, Dorota and Halat-Wolska, Paulina and Błaszkiewicz, Jagoda and Mendrek, Izabela and Chrzanowska, Krystyna and Młynek, Marlena and Stawiński, Piotr and Kosińska, Joanna and Krajewska-Walasek, Małgorzata and Ciara, Elżbieta},
  title = {Rubinstein–Taybi Syndrome: A Comprehensive Analysis of a Polish Cohort with Most Cases Due to Novel CREBBP and EP300 Variants},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16101206}
}
Kostenlos starten →